Terumo Corp. (TYO:4543) and Cognate BioServices said today they inked a collaborative cellular and immunotherapy products development deal.
Get the rest of the story at our sister site, Medical Design & Outsourcing
The post Terumo inks regenerative collab deal with Cognate BioServices appeared first on MassDevice.
from MassDevice http://ift.tt/2ddsGGk
Cap comentari:
Publica un comentari a l'entrada